Wells Fargo & Company »

Evommune shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $89k 3.9k 22.99

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management
BlackRock

View all funds holding Evommune